Navigation Links
Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
Date:10/6/2010

SAN DIEGO and WOODCLIFF LAKE, N.J., Oct. 6, 2010 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today upcoming lorcaserin presentations at Obesity 2010, the 28th Annual Scientific Meeting of The Obesity Society, in San Diego, California. Lorcaserin, which Arena discovered and developed, is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (Body Mass Index, or BMI, >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.

"Obesity 2010 is an excellent scientific forum to present results from our recently completed clinical study evaluating the effects of lorcaserin on appetite, energy intake and energy expenditure," stated William R. Shanahan, M.D., Arena's Senior Vice President and Chief Medical Officer. "We look forward to presenting at this event, and to lorcaserin's October 22nd PDUFA date."

The meeting schedule includes presentations of a lorcaserin mechanism of action study conducted by Drs. Eric Ravussin, Leanne Redman, Corby Martin and Steven Smith at the Pennington Biomedical Research Center in Baton Rouge, Louisiana.

Saturday, October 9, 2010

  • Oral Abstract Presentation: Lorcaserin, a Novel 5-HT2C Receptor Agonist, Causes Weight Loss Without Stimulating Energy Expenditure
  • Session Time:  4:45 p.m. - 6:15 p.m. Pacific Time (PT)

  • Sunday, October 10, 2010

  • Poster Presentation: Lorcaserin, a Selective 5-HT2C Receptor Agonist, Reduces Energy Intake and Appetite
  • Session Time: The poster will be on display from 9:30 a.m. to 1:45 p.m. PT and from 3:15 p.m. to 6:30 p.m. PT. Presenters will be available to discuss the poster from 12:30 p.m. to 1:30 p.m. PT.

  • About LorcaserinLorcaserin is a new chemical entity that is
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
    2. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
    3. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
    4. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
    5. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
    6. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
    7. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
    8. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
    9. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
    10. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
    11. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2015)... , April 27, 2015 NxStage Medical, Inc. ... products, today announced that Jeffrey H. Burbank , Chief ... Care Conference in Boston, MA on ... A webcast of the event will be made available ... About NxStage NxStage Medical, Inc. ...
    (Date:4/27/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... for human disease, will release its first quarter 2015 ... financial markets close.  Lexicon management will hold a conference ... financial results for the first quarter 2015 at 5:00 ... The dial-in number for the conference call is 888-645-5785 ...
    (Date:4/27/2015)... 27, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that it ... Food and Drug Administration ("FDA") verifying that the Company ... the warning letter it received from the FDA in ... re-inspection in March 2015 by the FDA at CryoLife,s ...
    Breaking Medicine Technology:NxStage to Present at the 40th Annual Deutsche Bank Securities Health Care Conference 2Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2
    ... the new screening guidelines announced by the National,Comprehensive Cancer ... will encourage those at high risk for lung cancer ... LCA President Laurie Fenton Ambrose said that lung ... all the other major cancers combined,until more at risk ...
    ... ILE ) announced today the completion of ... Study IT-A-008 investigating the Isolagen,Therapy(TM) for the treatment ... be administered at seven clinical sites across the ... Therapy could hold great promise for the,treatment of ...
    Cached Medicine Technology:Lung Cancer Alliance Commends NCCN on Screening Guidelines 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 2Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study 3
    (Date:4/28/2015)... 2015 SeniorCare.com has published the ... reality problem Americans have regarding aging and long-term care ... care services as they age, 63% of Americans do ... In the report, Carol Marak of SeniorCare.com interviewed 44 ... Health Care Association and The Scan Foundation. The experts ...
    (Date:4/28/2015)... FL (PRWEB) April 28, 2015 ... organization which provides vascular, electrocardiogram, echocardiogram, and NCV ... non-invasive vascular testing to help podiatrists diagnose peripheral ... challenging to diagnose PAD without the aid of ... Chief Medical Officer at Wimbledon Health Partners. ...
    (Date:4/28/2015)... MO (PRWEB) April 28, 2015 The ... 2015 from 5:00 to 8:00 pm at the Sheraton Colonial ... than 50 hospitals, clinics and groups with career opportunities will ... represented. Attendees will enjoy free hors d’oeuvres and raffle prize ... PracticeMatch says “Boston is an ideal location to hold ...
    (Date:4/28/2015)... (PRWEB) April 28, 2015 The Awareness Counselor ... the common topic of judging. According to Awareness Counselor, there ... people, when directed outward, and to an individual who self-judges. ... new clients as a class or one one one talk. ... founder of Awareness Counselor, is that every being on earth ...
    (Date:4/28/2015)... Aliso Viejo, CA (PRWEB) April 28, 2015 ... created for use in Final Cut Pro X ... attention to specific areas on-screen with classic buttons, animated ... Annotate is the perfect compliment to vlogs, video series, ... Cut Pro X 10.2 or newer. ProTube Annotate ...
    Breaking Medicine News(10 mins):Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 2Health News:PracticeMatch to Host Physician Career Fair at Sheraton Colonial Boston North Hotel on May 6, 2015 3Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:FCPX plugin developer Pixel Film Studios releases Protube Annotate plugin for Final Cut Pro X. 2
    ... A Dartmouth-led study of young U.S. teens showed that ... items featuring an alcohol brand, and those who do ... drinking from susceptibility, to beginning drinking, to binge drinking, ... Archives of Pediatrics & Adolescent Medicine . , ...
    ... study finds , , TUESDAY, March 3 (HealthDay News) -- The ... the worse his sex life, a new study finds. , ... bypass surgery can help reverse those ills. , "Previous studies ... and can be associated with infertility, but we wanted to ...
    ... long-term investment and social responsibility in industry categoryMADISON, N.J., ... DGX ), the world,s leading provider of diagnostic testing, ... magazine,s list of the World,s Most Admired Companies. Quest ... "Pharmacy and Other Services." The 2009 ranking is the ...
    ... long-term care insurance. , ... Newark, NJ (PRWEB) March 3, 2009 -- ... you off, Prudential has a way out the maze. Prudential ... confuse the decision-making process., , , , ,Although its design is simpler, ...
    ... of the World,s Most Admired CompaniesEL SEGUNDO, Calif., March ... care services, today accepted the honor by FORTUNE ... facilities in the country. DaVita(R) ranked #1 in the ... Investment and Quality of Products and Services. Overall, the ...
    ... LITTLE FALLS, N.J., March 3 Cantel Medical Corp. (NYSE: ... discuss the Company,s results for its second quarter ended January ... Participating in the call will be Charles M. Diker, ... President and CFO; and Roy K. Malkin, President of Minntech ...
    Cached Medicine News:Health News:Owning alcohol-branded merchandise associated with teen drinking behaviors 2Health News:Men's Sex Lives May Suffer as Waistlines Expand 2Health News:Quest Diagnostics Again Named to FORTUNE Magazine's 'World's Most Admired Companies' List 2Health News:Prudential Long-Term Care Product Simplifies Decisions 2Health News:Prudential Long-Term Care Product Simplifies Decisions 3Health News:FORTUNE Magazine Ranks DaVita #1 Health Care Medical Facility in Innovation, Investment and Quality 2Health News:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Second Quarter Ended January 31, 2009 2
    ... is a fully automated, benchtop coagulation ... and immunological assays in true random ... of sample management offers high throughput ... without the need to interrupt current ...
    The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
    ... The ACL 100 is ... volume workloads, or as a ... also runs clotting assays, such ... Plus, it's backed by superior ...
    ... StatSite MHgb test system is ... dedicated hemoglobin test system designed ... public health clinics, blood centers ... portable system is designed for ...
    Medicine Products: